ETFChannel.com
ARK Genomic Revolution ETF

Fund Name:
ARK Genomic Revolution ETF
Issuer:
ARK Invest
Total Net Assets:
$2,416,335,557
Inception:
10/31/2014
Related Index:
Active Equity ETF
Expense Ratio: 
0.75% 
Net Asset Value: 
$32.97  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
ARKG.NV  
Number of Holdings: 
Variable  
Annualized Yield: 
0.00%  
Annualized Distribution: 
0.00  
Stock Weight Amount
Exact Sciences 6.82% $164,682,721
Ionis Pharmaceuticals 6.44% $155,646,464
Signify Health Inc -class A 4.37% $105,551,080
Crispr Therapeutics AG 4.36% $105,233,621
Teladoc Health 4.36% $105,381,989
List of all 48 stocks held by ARKG »
Quotes delayed 20 minutes

Email EnvelopeFree ARKG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.16 out of 4)
25th percentile
(ranked lower than approx. 75% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com

ARKG | ARK Genomic Revolution ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.